| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMDC.201700653 |
| P8608 | Fatcat ID | release_bt4vklcso5f7llkdhvmpehoepu |
| P698 | PubMed publication ID | 29314706 |
| P50 | author | Santosh Kumar | Q44565398 |
| Moneesha Fernandes | Q87897073 | ||
| Souvik Maiti | Q18217615 | ||
| P2093 | author name string | Durba Sengupta | |
| Govind S Bhosle | |||
| Shalmali Kharche | |||
| P2860 | cites work | Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors | Q38212101 |
| A Peptide Nucleic Acid–Aminosugar Conjugate Targeting Transactivation Response Element of HIV-1 RNA Genome Shows a High Bioavailability in Human Cells and Strongly Inhibits Tat-Mediated Transactivation of HIV-1 Transcription | Q38324450 | ||
| Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble | Q39517694 | ||
| Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA. | Q40558667 | ||
| A preorganized β-amino acid bearing a guanidinium side chain and its use in cell-penetrating peptides | Q41034490 | ||
| Thermodynamics of Peptide−RNA Recognition: The Binding of a Tat Peptide to TAR RNA | Q42945518 | ||
| A new class of RNA-binding oligomers: peptoid amide and ester analogues | Q43429347 | ||
| Arginine-mediated RNA recognition: the arginine fork. | Q44511258 | ||
| Fragments of the HIV-1 Tat protein specifically bind TAR RNA. | Q45148606 | ||
| Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides | Q45749893 | ||
| Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors | Q46436126 | ||
| Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models | Q51723838 | ||
| Cell surface adherence and endocytosis of protein transduction domains | Q51835694 | ||
| Correction: Hybrid Approach for Predicting Coreceptor Used by HIV-1 from Its V3 Loop Amino Acid Sequence. | Q55434721 | ||
| Targeting RNA with Small Molecules | Q79109988 | ||
| Polymorphic transitions in single crystals: A new molecular dynamics method | Q97681190 | ||
| Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots" | Q27643071 | ||
| Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus | Q27643539 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| Satisfying hydrogen bonding potential in proteins | Q27860940 | ||
| GROMACS: fast, flexible, and free | Q27860998 | ||
| Isothermal titration calorimetry of protein-protein interactions | Q28145988 | ||
| Inhibition of gene expression in human cells through small molecule-RNA interactions | Q28343697 | ||
| An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication | Q28379540 | ||
| Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA | Q28478188 | ||
| Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations | Q29038325 | ||
| Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
| NPDock: a web server for protein-nucleic acid docking | Q30374706 | ||
| Targeting RNA with peptidomimetic oligomers in human cells | Q32068280 | ||
| RNA as a target for drug design, the example of Tat-TAR interaction. | Q33184053 | ||
| Peptoids: a modular approach to drug discovery. | Q33191665 | ||
| Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements | Q33203378 | ||
| Screening of a branched peptide library with HIV-1 TAR RNA. | Q33492394 | ||
| Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro | Q33900660 | ||
| Recognition of HIV TAR RNA by triazole linked neomycin dimers | Q33961121 | ||
| Branched peptide boronic acids (BPBAs): a novel mode of binding towards RNA. | Q34587957 | ||
| Drugs targeting the ribosome | Q36140961 | ||
| Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves | Q36472087 | ||
| Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription | Q36870972 | ||
| Specific binding of arginine to TAR RNA | Q36918014 | ||
| What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? | Q37220038 | ||
| Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator | Q37251783 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 220-226 | |
| P577 | publication date | 2018-01-15 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Superior HIV-1 TAR Binders with Conformationally Constrained R52 Arginine Mimics in the Tat(48-57) Peptide | |
| P478 | volume | 13 |
Search more.